HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders.

Abstract
The literature on non-genetic peripheral biomarkers for major mental disorders is broad, with conflicting results. An umbrella review of meta-analyses of non-genetic peripheral biomarkers for Alzheimer's disease, autism spectrum disorder, bipolar disorder (BD), major depressive disorder, and schizophrenia, including first-episode psychosis. We included meta-analyses that compared alterations in peripheral biomarkers between participants with mental disorders to controls (i.e., between-group meta-analyses) and that assessed biomarkers after treatment (i.e., within-group meta-analyses). Evidence for association was hierarchically graded using a priori defined criteria against several biases. The Assessment of Multiple Systematic Reviews (AMSTAR) instrument was used to investigate study quality. 1161 references were screened. 110 met inclusion criteria, relating to 359 meta-analytic estimates and 733,316 measurements, on 162 different biomarkers. Only two estimates met a priori defined criteria for convincing evidence (elevated awakening cortisol levels in euthymic BD participants relative to controls and decreased pyridoxal levels in participants with schizophrenia relative to controls). Of 42 estimates which met criteria for highly suggestive evidence only five biomarker aberrations occurred in more than one disorder. Only 15 meta-analyses had a power >0.8 to detect a small effect size, and most (81.9%) meta-analyses had high heterogeneity. Although some associations met criteria for either convincing or highly suggestive evidence, overall the vast literature of peripheral biomarkers for major mental disorders is affected by bias and is underpowered. No convincing evidence supported the existence of a trans-diagnostic biomarker. Adequately powered and methodologically sound future large collaborative studies are warranted.
AuthorsAndré F Carvalho, Marco Solmi, Marcos Sanches, Myrela O Machado, Brendon Stubbs, Olesya Ajnakina, Chelsea Sherman, Yue Ran Sun, Celina S Liu, Andre R Brunoni, Giorgio Pigato, Brisa S Fernandes, Beatrice Bortolato, Muhammad I Husain, Elena Dragioti, Joseph Firth, Theodore D Cosco, Michael Maes, Michael Berk, Krista L Lanctôt, Eduard Vieta, Diego A Pizzagalli, Lee Smith, Paolo Fusar-Poli, Paul A Kurdyak, Michele Fornaro, Jürgen Rehm, Nathan Herrmann
JournalTranslational psychiatry (Transl Psychiatry) Vol. 10 Issue 1 Pg. 152 (05 18 2020) ISSN: 2158-3188 [Electronic] United States
PMID32424116 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Biomarkers
Topics
  • Autism Spectrum Disorder
  • Biomarkers
  • Bipolar Disorder (diagnosis)
  • Depressive Disorder, Major
  • Humans
  • Mental Disorders
  • Schizophrenia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: